{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:46:27Z","timestamp":1773413187148,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15779","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:55:16Z","timestamp":1682650516000},"page":"e15779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8222-0132","authenticated-orcid":false,"given":"Yimam","family":"Getaneh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadesse","family":"Lejissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tigist","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti qamariyah","family":"khairunisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominicus","family":"Husada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuntaman","family":"Kuntaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Inge","family":"Lusida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e15779_bib1","series-title":"A Review of the Toxicity of HIV Medications","first-page":"26","author":"Margolis","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e15779_bib2","volume":"vol. 212","author":"Abraham","year":"2015"},{"issue":"9239","key":"10.1016\/j.heliyon.2023.e15779_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e15779_bib6","series-title":"Mitochondrial Toxicity and HIV Therapy Review","first-page":"158","author":"White","year":"2001"},{"issue":"9875","key":"10.1016\/j.heliyon.2023.e15779_bib4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(12)62198-9","article-title":"Routine versus clinically driven laboratory monitoring and fi rst-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial","volume":"381","author":"Gibb","year":"2013","journal-title":"Lancet"},{"issue":"20 II","key":"10.1016\/j.heliyon.2023.e15779_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0755-4982(05)84227-7","article-title":"Adverse effects of antiretroviral treatments","volume":"34","author":"Lagrange-X\u00e9lot","year":"2005","journal-title":"Presse Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15779_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e318221c56a","article-title":"Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children","volume":"57","author":"Heidari","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15779_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4236\/ti.2016.73013","article-title":"Assessment of renal function among HIV-infected patients on combination antiretroviral therapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia","volume":"7","author":"Eneyew","year":"2016","journal-title":"Technol. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15779_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-019-4748-4","article-title":"Liver enzyme elevation in patients taking HAART compared with treatment na\u00efve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia","volume":"12","author":"Tesfa","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.heliyon.2023.e15779_bib11","article-title":"Liver enzymes abnormalities among highly active antiretroviral therapy experienced and HAART na\u00efve HIV-1 infected patients at Debre tabor hospital, north west Ethiopia: a comparative cross-sectional study","volume":"2016","author":"Shiferaw","year":"2016","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.heliyon.2023.e15779_bib12","series-title":"Atazanavir Trough Plasma Concentration Monitoring in a Cohort of HIV-1-Positive Individuals Receiving Highly Active Antiretroviral Therapy","first-page":"380","author":"Winston","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e15779_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu730","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV : 2014 update by the HIV medicine association of the infectious diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15779_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","article-title":"Kidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15779_bib14","first-page":"1","article-title":"Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without","volume":"7","author":"Mugusi","year":"2012","journal-title":"Tuberculosis Co-Infection in Tanzania"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15779_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0032-1316472","article-title":"Liver toxicity of antiretroviral drugs","volume":"32","author":"Jones","year":"2012","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15779_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-2288-8","article-title":"Hematological reference intervals determination in adults at Gondar university hospital, Northwest Ethiopia","volume":"9","author":"Yalew","year":"2016","journal-title":"BMC Res. Notes"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15779_bib17","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.3390\/nu7115468","article-title":"Inverse correlation between vitamin D and C-reactive protein in newborns","volume":"7","author":"Tao","year":"2015","journal-title":"Nutrients"},{"issue":"1\u20134","key":"10.1016\/j.heliyon.2023.e15779_bib18","article-title":"C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status","year":"2014","journal-title":"Vitam. Miner. Nutr. Inf. Syst"},{"key":"10.1016\/j.heliyon.2023.e15779_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/735615","article-title":"Vitamin D deficiency in HIV infection: not only a bone disorder","volume":"2015","author":"Mansueto","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e15779_bib20","first-page":"123","article-title":"Role of high - sensitivity C","author":"Nehru","year":"2016","journal-title":"reactive protein measurements in HIV patients"},{"key":"10.1016\/j.heliyon.2023.e15779_bib21","first-page":"1","article-title":"C - reactive protein and interleukin","author":"Nkinda","year":"2019","journal-title":"6 levels among human immunodeficiency virus -infected patients with dysglycemia in Tanzania"},{"key":"10.1016\/j.heliyon.2023.e15779_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/PHMT.S129362","article-title":"Vitamin D deficiency and anemia risk in children: a review of emerging evidence","volume":"8","author":"Uwaezuoke","year":"2017","journal-title":"Pediatr. Health Med. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e15779_bib23","first-page":"1","article-title":"Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir\/ritonavir-based therapy","volume":"310","author":"Id","year":"2019","journal-title":"Substudy of a randomized trial"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15779_bib24","first-page":"1","article-title":"NIH public access","volume":"23","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.heliyon.2023.e15779_bib25","first-page":"64","article-title":"C-reactive protein is a marker for human immunodeficiency","volume":"166","author":"Lau","year":"2006","journal-title":"Virus Disease Progression"},{"key":"10.1016\/j.heliyon.2023.e15779_bib26","article-title":"Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis relationship of serum cystatin","volume":"6049","author":"Samouilidou","year":"2009","journal-title":"C with C-Reactive Protein and Apolipoprotein A1 in Patients on Hemodialysis"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15779_bib27","article-title":"Nevirapine toxicity","volume":"95","author":"Wood","year":"2005","journal-title":"implications for management of South African patients"},{"key":"10.1016\/j.heliyon.2023.e15779_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/HIV.S232146","article-title":"First report on HHV-6 infection among hiv-infected individuals residing in Surabaya, Indonesia","volume":"12","author":"Oktafiani","year":"2020","journal-title":"HIV AIDS Res. Palliat. Care"},{"key":"10.1016\/j.heliyon.2023.e15779_bib29","doi-asserted-by":"crossref","unstructured":"C. C. Chang et al., \u201cHIV and co-infections,\u201d vol. 254, pp. 114\u2013142, 2013.","DOI":"10.1111\/imr.12063"},{"key":"10.1016\/j.heliyon.2023.e15779_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","article-title":"Higher levels of CRP , D-dimer , IL-6 , and hyaluronic acid before initiation of antiretroviral therapy (ART) Are Associated With Increased Risk of AIDS or Death","volume":"203","author":"Boulware","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e15779_bib31","first-page":"11","volume":"vol. 24","year":"2008"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15779_bib32","first-page":"371","article-title":"m er ci al us e on om m","volume":"3","author":"Eridani","year":"2011","journal-title":"er ci al us e Genetic factors"},{"key":"10.1016\/j.heliyon.2023.e15779_bib33","first-page":"1","article-title":"AIDS Research and Therapy Predictors of disease progression in HIV infection","volume":"14","author":"Langford","year":"2007","journal-title":"a review"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15779_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-019-4748-4","article-title":"Liver enzyme elevation in patients taking HAART compared with treatment na\u00efve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia","volume":"12","author":"Tesfa","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.heliyon.2023.e15779_bib35","first-page":"1","article-title":"Assessment of the effect of antiretroviral therapy on renal and liver functions among HIV-infected patients : a retrospective study","author":"Care","year":"2017","journal-title":"HIV AIDS (Auckl)"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15779_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7150\/ntno.73918","article-title":"Progress on applying carbon dots for inhibition of RNA virus infection","volume":"6","author":"Kwee","year":"2022","journal-title":"Nanotheranostics"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15779_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/aid.2009.0012","article-title":"Primary antiretroviral drug resistance among HIV Type 1-infected individuals in Brazil","volume":"25","author":"Sprinz","year":"2009","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.heliyon.2023.e15779_bib38","series-title":"The Federal Democratic Republic of Ethiopia Ministry of Health","first-page":"1","year":"2006"},{"key":"10.1016\/j.heliyon.2023.e15779_bib39","series-title":"Ethiopia Demographic and Health Survey 2016","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e15779_bib40","article-title":"Analysing regional performance and disparities in health outcomes in Ethiopia","volume":"2","author":"Bwalya","year":"2012","journal-title":"Undp"},{"issue":"\u20139","key":"10.1016\/j.heliyon.2023.e15779_bib41","first-page":"1","article-title":"Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: the protocol for a randomized double blinded placebo controlled efficacy trial","volume":"12","author":"Guwatudde","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e15779_bib42","first-page":"331","article-title":"HIV\/AIDS prevention and treatment","author":"Bertozzi","year":"2005","journal-title":"Dis. Control priorities Dev. Ctries."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15779_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874613602115010001","article-title":"Determinants of the discriminatory behavior experienced by people living with HIV in Indonesia: a cross-sectional study of the demographic health survey","volume":"15","author":"Nursalam","year":"2021","journal-title":"Open AIDS J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:19:18Z","timestamp":1773397158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023029869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405844023029869"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15779","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15779"}}